Search Results 31-38 of 38 for ‼케이카지노 【원벳원보증.com / 가입코드 9192】 원벳원가입코드 ‼

  1. Kwan S. Lee, M.B., B.Ch., M.D.

    2009. FellowInterventional Cardiology Fellowship, Emory University School of Medicine · 2008. FellowCardiovascular Diseases Fellowship, Internal Medicine, ...

  2. Epoetin alfa-epbx (injection route) - Side effects & dosage - Mayo Clinic

    Epoetin alfa-epbx injection is used to treat anemia in patients with chronic kidney disease (CKD) who may or may not be on dialysis. This medicine may also be ...

  3. A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II) - Mayo Clinic

    The purpose of this study is to address an unmet need for a targeted treatment against BK polyomavirus (BKV) associated nephropathy (BKVAN) in kidney transplant ...

  5. Erectile dysfunction and diabetes: Take control today - Mayo Clinic

    Erectile dysfunction is a common problem for men who have diabetes — but it's not inevitable. Consider prevention strategies, treatment options and more.

  6. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) - Mayo Clinic

    The purpose of this study is to evaluate the safety and efficacy of [177Lu]Lu-FAP-2286 as monotherapy in participants with pancreatic ductal adenocarcinoma ( ...

  7. Erectile dysfunction - Doctors and departments - Mayo Clinic

    Know what can cause not being able to get and keep an erection for sexual activity and the possible treatments.

  8. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    This phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate ...